Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (291-300 of 408) with videos related to

Pageof 41
Sort By:
Cytokine|May 24, 2011
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10Alessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Frontiers in Cardiovascular Medicine|February 21, 2022
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in HumansEle Ferrannini, Maria Laura Manca, Giulia Ferrannini, et al.
Hypertension (Dallas, Tex. : 1979)|July 21, 2004
Visceral fat in hypertension: influence on insulin resistance and beta-cell functionAnna Maria Sironi, Amalia Gastaldelli, Andrea Mari, et al.
American Journal of Physiology. Renal Physiology|February 1, 2007
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4Anna Solini, Eleonora Santini, Daniele Chimenti, et al.
Clinical Science (London, England : 1979)|November 4, 2017
GLP-1 response to sequential mixed meals: influence of insulin resistanceEleni Rebelos, Brenno Astiarraga, Roberto Bizzotto, et al.
The Journal of Clinical Endocrinology and Metabolism|May 24, 2011
Obesity and type 2 diabetes: what can be unified and what needs to be individualized?Robert H Eckel, Steven E Kahn, Ele Ferrannini, et al.
Diabetes, Obesity & Metabolism|February 14, 2020
Brain free fatty acid uptake is elevated in morbid obesity, and is irreversible 6 months after bariatric surgery: A positron emission tomography studyEleni Rebelos, Jussi Hirvonen, Marco Bucci, et al.
Diabetes, Obesity & Metabolism|August 2, 2021
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairmentDavid Z I Cherney, Ele Ferrannini, Guillermo E Umpierrez, et al.
Scientific Reports|May 23, 2018
Publisher Correction: Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgeryStefania Camastra, Alessandra Vitali, Marco Anselmino, et al.
Molecular and Cellular Endocrinology|November 22, 2011
Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves' ophthalmopathy fibroblasts and preadipocytesAlessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Pageof 41

Showing results (291-300 of 408) with videos related to

Sort By:
Pageof 41
Cytokine|May 24, 2011
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10Alessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Frontiers in Cardiovascular Medicine|February 21, 2022
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in HumansEle Ferrannini, Maria Laura Manca, Giulia Ferrannini, et al.
Hypertension (Dallas, Tex. : 1979)|July 21, 2004
Visceral fat in hypertension: influence on insulin resistance and beta-cell functionAnna Maria Sironi, Amalia Gastaldelli, Andrea Mari, et al.
American Journal of Physiology. Renal Physiology|February 1, 2007
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4Anna Solini, Eleonora Santini, Daniele Chimenti, et al.
Clinical Science (London, England : 1979)|November 4, 2017
GLP-1 response to sequential mixed meals: influence of insulin resistanceEleni Rebelos, Brenno Astiarraga, Roberto Bizzotto, et al.
The Journal of Clinical Endocrinology and Metabolism|May 24, 2011
Obesity and type 2 diabetes: what can be unified and what needs to be individualized?Robert H Eckel, Steven E Kahn, Ele Ferrannini, et al.
Diabetes, Obesity & Metabolism|February 14, 2020
Brain free fatty acid uptake is elevated in morbid obesity, and is irreversible 6 months after bariatric surgery: A positron emission tomography studyEleni Rebelos, Jussi Hirvonen, Marco Bucci, et al.
Diabetes, Obesity & Metabolism|August 2, 2021
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairmentDavid Z I Cherney, Ele Ferrannini, Guillermo E Umpierrez, et al.
Scientific Reports|May 23, 2018
Publisher Correction: Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgeryStefania Camastra, Alessandra Vitali, Marco Anselmino, et al.
Molecular and Cellular Endocrinology|November 22, 2011
Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves' ophthalmopathy fibroblasts and preadipocytesAlessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Pageof 41